Literature DB >> 20647062

Interleukin-17-producing T helper cells in autoimmunity.

Nasr Y A Hemdan1, Gerd Birkenmeier, Gunnar Wichmann, Ahmed M Abu El-Saad, Thorsten Krieger, Karsten Conrad, Ulrich Sack.   

Abstract

With all the incredible progress in scientific research over the past two decades, the trigger of the majority of autoimmune disorders remains largely elusive. Research on the biology of T helper type 17 (T(H)17) cells over the last decade not only clarified previous observations of immune regulations and disease manifestations, but also provided considerable information on the signaling pathways mediating the effects of this lineage and its seemingly dual role in fighting the invading pathogens on one hand, and in frightening the host by inducing chronic inflammation and autoimmunity on the other hand. In this context, recent reports have implicated T(H)17 cells in mediating host defense as well as a growing list of autoimmune diseases in genetically-susceptible individuals. Herein, we summarize the current knowledge on T(H)17 in autoimmunity with emphasis on its differentiation factors and some mechanisms involved in initiating pathological events of autoimmunity. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20647062     DOI: 10.1016/j.autrev.2010.07.003

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  46 in total

1.  A CCR6 variant strongly associated with rheumatoid arthritis in two populations is not associated with ankylosing spondylitis.

Authors:  Carla J Cohen; Tugce Karaderi; Jennifer J Pointon; B Paul Wordsworth
Journal:  Rheumatol Int       Date:  2012-04-08       Impact factor: 2.631

2.  The tyrosine phosphatase SHP-1 dampens murine Th17 development.

Authors:  Ileana S Mauldin; Kenneth S Tung; Ulrike M Lorenz
Journal:  Blood       Date:  2012-03-20       Impact factor: 22.113

Review 3.  Function of Act1 in IL-17 family signaling and autoimmunity.

Authors:  Ling Wu; Jarod Zepp; Xiaoxia Li
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

4.  MiR-23b is a safeguard against autoimmunity.

Authors:  Ruozhen Hu; Ryan M O'Connell
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

Review 5.  IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease.

Authors:  Jarod Zepp; Ling Wu; Xiaoxia Li
Journal:  Trends Immunol       Date:  2011-04-12       Impact factor: 16.687

Review 6.  New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action?

Authors:  Margaret E Walker; Julianne K Hatfield; Melissa A Brown
Journal:  Biochim Biophys Acta       Date:  2011-02-25

Review 7.  The autoimmune side of heart and lung diseases.

Authors:  Nancy Agmon-Levin; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

8.  Detection of dynamic frequencies of Th17 cells and their associations with clinical parameters in patients with systemic lupus erythematosus receiving standard therapy.

Authors:  Zhenke Wen; Lin Xu; Wei Xu; Sidong Xiong
Journal:  Clin Rheumatol       Date:  2014-05-10       Impact factor: 2.980

9.  IL-17 induces expression of vascular cell adhesion molecule through signalling pathway of NF-κB, but not Akt1 and TAK1 in vascular smooth muscle cells.

Authors:  H Zhang; J Chen; X Liu; L Awar; A McMickle; F Bai; S Nagarajan; S Yu
Journal:  Scand J Immunol       Date:  2013-04       Impact factor: 3.487

Review 10.  Chronic rejection: a significant role for Th17-mediated autoimmune responses to self-antigens.

Authors:  Vijay Subramanian; Thalachallour Mohanakumar
Journal:  Expert Rev Clin Immunol       Date:  2012-09       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.